rs2461248
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000520388.5(DMGDH):n.492-330T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.412 in 151,986 control chromosomes in the GnomAD database, including 15,317 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 15317 hom., cov: 31)
Consequence
DMGDH
ENST00000520388.5 intron
ENST00000520388.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.117
Publications
4 publications found
Genes affected
DMGDH (HGNC:24475): (dimethylglycine dehydrogenase) This gene encodes an enzyme involved in the catabolism of choline, catalyzing the oxidative demethylation of dimethylglycine to form sarcosine. The enzyme is found as a monomer in the mitochondrial matrix, and uses flavin adenine dinucleotide and folate as cofactors. Mutation in this gene causes dimethylglycine dehydrogenase deficiency, characterized by a fishlike body odor, chronic muscle fatigue, and elevated levels of the muscle form of creatine kinase in serum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
DMGDH Gene-Disease associations (from GenCC):
- dimethylglycine dehydrogenase deficiencyInheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.589 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMGDH | ENST00000520388.5 | n.492-330T>A | intron_variant | Intron 3 of 4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.412 AC: 62581AN: 151868Hom.: 15310 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
62581
AN:
151868
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.412 AC: 62591AN: 151986Hom.: 15317 Cov.: 31 AF XY: 0.417 AC XY: 30932AN XY: 74242 show subpopulations
GnomAD4 genome
AF:
AC:
62591
AN:
151986
Hom.:
Cov.:
31
AF XY:
AC XY:
30932
AN XY:
74242
show subpopulations
African (AFR)
AF:
AC:
5415
AN:
41476
American (AMR)
AF:
AC:
8040
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1316
AN:
3468
East Asian (EAS)
AF:
AC:
3142
AN:
5176
South Asian (SAS)
AF:
AC:
2191
AN:
4798
European-Finnish (FIN)
AF:
AC:
6078
AN:
10516
Middle Eastern (MID)
AF:
AC:
135
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34725
AN:
67966
Other (OTH)
AF:
AC:
917
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1660
3320
4981
6641
8301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1758
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.